Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
about
Chronic fatigue syndromeHigh levels of type 2 cytokine-producing cells in chronic fatigue syndromeNeural immune pathways and their connection to inflammatory diseasesCortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormonesHypothalamic-pituitary-gonadal axis hormones and cortisol in both menstrual phases of women with chronic fatigue syndrome and effect of depressive mood on these hormonesClinical and biochemical manifestations of depression: relation to the neurobiology of stressA Window on the Study of Aversive Instrumental Learning: Strains, Performance, Neuroendocrine, and Immunologic Systems.Chronic subordinate colony housing paradigm: a mouse model to characterize the consequences of insufficient glucocorticoid signaling.Impaired adrenergic- and corticotropic-axis outflow during exercise in chronic obstructive pulmonary disease.Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?Acute stress induces hyperacusis in women with high levels of emotional exhaustion.Acculturation, childhood trauma and the cortisol awakening response in Mexican-American adults.Chronic activation of corticotropin-releasing factor type 2 receptors reveals a key role for 5-HT1A receptor responsiveness in mediating behavioral and serotonergic responses to stressful challenge.The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups.Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome.The pathophysiology of chronic fatigue syndrome: confirmations, contradictions, and conjectures.Interpreter of maladies: redescription mining applied to biomedical data analysis.Neuroaetiology of chronic fatigue syndrome: an overview.The demand control model and circadian saliva cortisol variations in a Swedish population based sample (The PART study).Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction.Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers.Immune system-central nervous system interactions: effect and immunomodulatory consequences of immune system mediators on the brain.Chronic fatigue syndrome: new insights and old ignorance.Biomarkers in the Study of Families of Individuals with Developmental Disabilities.Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome.EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients--a case control study.Chronic fatigue syndrome or just plain tired?Neuroendocrine and immune contributors to fatigueEBV Chronic InfectionsPhysiological differences between burnout patients and healthy controls: blood pressure, heart rate, and cortisol responses.Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome.A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior.Association between chronic fatigue syndrome and the corticosteroid-binding globulin gene ALA SER224 polymorphism.alpha-Interferon treatment of patients with chronic fatigue syndrome.Chronic fatigue syndrome. Helping patients cope with this enigmatic illness.Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue.Clinical methodology and its implications for the study of therapeutic interventions for chronic fatigue syndrome: a commentary.Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.Extrahepatic manifestations of cholestasis.
P2860
Q24524596-2B56E206-0921-498B-975B-851D249656F4Q24684394-C3DBA4FC-5C29-41C5-8F09-977DEB28B76EQ24794997-6BEFC89C-4591-4BEB-8DA8-826634549DB2Q24800577-5D98C0B0-6F9D-4DDB-A115-FA9C5E681B47Q24809802-7288DCA0-F2E5-4BF9-8216-2AA0FE8D67BFQ26824899-0CB50635-6814-4B86-A354-A7DC13584A03Q27320595-DCFC3956-ECD2-4062-8EDA-C2D5E9E07566Q30417042-9EBD78D5-AEC3-4B68-9261-D35000A75D51Q30424340-42E9B296-0763-4095-AB68-75273A2A15DFQ30447974-11FFCDDC-B264-49EA-87E3-C020E5B050DFQ30459317-5679C3B4-B7F9-44E3-98DC-FAF88C92C093Q30474299-F3BD8E5D-C28B-44B9-A650-D303B736EAC5Q30524485-7D9D52EC-31AF-44BF-9AAB-A3A08DCF03D5Q30575382-1770649F-AA43-4238-86B0-B1A9405BC123Q30613370-6564A309-397A-43C8-9997-9EE339CF9216Q30834887-8F3E34A7-1E9A-4D81-9D08-1BB4978BF9F6Q31036504-2B65ED43-2951-4609-AB99-29A975204340Q31127930-A6C3A48F-DA70-4F6B-B692-65AEDF6435B6Q33264730-4AFE32C9-BE63-4854-B68A-2AFB8BAA0CC9Q33402443-6B7C47A6-837F-40C0-84B9-AF1736D85769Q33737919-A707A963-E501-40E7-8BF3-0E298F307FA1Q33746873-7E4C088C-762B-4308-8314-7909289DCADDQ33785889-4440D2D6-EA0C-4AAE-B208-AFC1A1FA7289Q33795272-F218C7BE-A3DB-4572-AEFA-17BF772B605CQ33933509-886D5252-1BBB-4572-A8D5-35F10F901C82Q33948741-FF8C21EB-31A8-47EE-A246-7A336A51D9F6Q34029612-FA7782AC-D9BB-46DB-B829-06EAF8904E98Q34103068-EC0DFFD3-BB1B-405B-A051-56F275836C29Q34171625-1A9F823F-F533-40DF-9838-3626D284AADEQ34202398-610B2DAD-44EA-4086-B284-DB015B26F98CQ34219361-1E590973-63DF-4D7C-AD5D-F3D70B992D8CQ34333249-329752C7-DA93-422F-85F3-E22EF5421DAFQ34369519-92FDD63C-E166-41C0-9E2C-B65E8ED1A987Q34386229-93D1BDF4-F77C-438C-82A8-92832F1724C2Q34454465-B2BC163E-44B4-4471-8BBB-D604A56B14C8Q34513067-1F8FF0F7-535F-4115-9634-C03202B3CC6AQ34513108-D4B60204-84C2-4556-9191-C41935A26ACBQ34580335-A27C4A59-C01A-42BF-A4C6-512B54316CC8Q34622270-6F7E441F-367E-4B50-A062-2D4D0F904EEBQ34776437-6F18F96A-63B9-429D-A063-5774B1C0E742
P2860
Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
description
1991 nî lūn-bûn
@nan
1991 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Evidence for impaired activati ...... with chronic fatigue syndrome.
@ast
Evidence for impaired activati ...... with chronic fatigue syndrome.
@en
Evidence for impaired activati ...... with chronic fatigue syndrome.
@nl
type
label
Evidence for impaired activati ...... with chronic fatigue syndrome.
@ast
Evidence for impaired activati ...... with chronic fatigue syndrome.
@en
Evidence for impaired activati ...... with chronic fatigue syndrome.
@nl
prefLabel
Evidence for impaired activati ...... with chronic fatigue syndrome.
@ast
Evidence for impaired activati ...... with chronic fatigue syndrome.
@en
Evidence for impaired activati ...... with chronic fatigue syndrome.
@nl
P2093
P356
P1476
Evidence for impaired activati ...... with chronic fatigue syndrome.
@en
P2093
Chrousos GP
Demitrack MA
Listwak SJ
P304
P356
10.1210/JCEM-73-6-1224
P407
P577
1991-12-01T00:00:00Z